Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

t is December 2022. You work as a financial analyst for Merck & Co. and are tasked with the due diligence on the proposed acquisition

t is December 2022. You work as a financial analyst for Merck & Co. and are tasked with the due diligence on the proposed acquisition of a biotech startup. You estimated the following cash flows for the startup:

Year Expected free cash flow ($ million) (end of year)
2023 89.5
2024 134.25
2025 174.53
2026 209.43
2027 230.37

After 2027, cash flows are expected to grow by 4% per year. Based on the riskiness of your industry, you think that your weighted average cost of capital is 18%.

The biotech firm has 5 million shares and bonds worth $120 million outstanding.

Attempt 4/10 for 10 pts.

Part 1

What is the terminal value, i.e., the present value of all free cash flows from 2028 to infinity expressed in 2027-dollars (in $ million)?

Submit

Attempt 1/10 for 10 pts.

Part 2

What is the total value of the company (in $ million)?

Submit

Attempt 1/10 for 10 pts.

Part 3

What is the value per share of common stock (in $)?

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Sport Funding And Finance

Authors: Bob Stewart

2nd Edition

041583984X, 978-0415839846

More Books

Students also viewed these Finance questions